Advertisement

Related Videos

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

David A. Hyman, MD, JD, on Inclusive Shared Savings

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

Advertisement

Advertisement




Jun
18
Today In Oncology
New ACSM Expert Consensus Statement: Exercise in Children and Adolescents With Cancer
Preclinical Research Shows Interferon May Attenuate Neutrophil Response to Cancer Immunotherapy
Low-Dose Tamoxifen in Noninvasive Breast Neoplasia
Relapsed or Refractory Multiple Myeloma Talquetamab Daratumumab
FDA Approves Capivasertib Plus Abiraterone and Prednisone for Metastatic Prostate Cancer
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo